| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EJPHAR.2007.10.054 |
| P698 | PubMed publication ID | 18031725 |
| P2093 | author name string | Akio Murase | |
| Hiroko Tonai-Kachi | |||
| Junji Takada | |||
| Kazunari Nakao | |||
| Takako Okumura | |||
| Ayano Sakakibara | |||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 116-121 | |
| P577 | publication date | 2007-10-30 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation | |
| P478 | volume | 580 |
| Q39710252 | A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models |
| Q39290501 | AKAP-dependent sensitization of Ca(v) 3.2 channels via the EP(4) receptor/cAMP pathway mediates PGE(2) -induced mechanical hyperalgesia |
| Q35633022 | Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E₂ in the spinal cord |
| Q36470228 | Analgesic effects of stem bark extracts of Trichilia monadelpha (Thonn.) JJ De Wilde |
| Q42682734 | Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation |
| Q38218630 | Interactions between glia, the immune system and pain processes during early development |
| Q35740060 | Matrix metalloproteinase-dependent microsomal prostaglandin E synthase-1 expression in macrophages: role of TNF-α and the EP4 prostanoid receptor |
| Q34546785 | Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit. |
| Q52680975 | Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug. |
| Q46493256 | Pharmacology of grapiprant, a novel EP4 antagonist: receptor binding, efficacy in a rodent postoperative pain model, and a dose estimation for controlling pain in dogs |
| Q33899147 | Prostaglandin E(2) binding peptide screened by phage displaying: a new therapeutic strategy in rheumatoid arthritis |
| Q35713568 | Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions |
| Q38162977 | Prostaglandin EP4 antagonists |
| Q33485483 | Prostanoid receptor antagonists: development strategies and therapeutic applications |
| Q26738309 | Structural features of subtype-selective EP receptor modulators |
| Q37813138 | Th17-cytokine blockers as a new approach for treating inflammatory bowel disease |
Search more.